Related Experiment Videos
Eosinophilia triggered by beta-interferon therapy for chronic hepatitis C
A Gattoni1, C Romano, A Cecere
1Department of Clinical and Experimental Medicine F. Magrassi, II University of Naples School of Medicine, Italy.
European Journal of Gastroenterology & Hepatology
|November 14, 1997
Summary
Beta-interferon therapy for chronic hepatitis C may trigger eosinophilia in atopic patients. This case report suggests a potential link between beta-interferon and the development of eosinophilia, a condition affecting white blood cells.
Area of Science:
- Hepatology
- Immunology
- Pharmacology
Background:
- Chronic active hepatitis C is a significant liver disease.
- Eosinophilia, an elevated eosinophil count, can be associated with various conditions.
- Beta-interferon is a therapeutic agent used in treating hepatitis C.